As an inhibitor of serum- and glucocorticoid-regulated kinases (SGK)28, GSK650394 has been shown to inhibit the proliferation of various human cancer cells, such as lung cancer29, thyroid cancer30, and human prostate cancer.28 This evidence concerns the gene SGK1 and prostate cancer.